$3.84
0.041.05%
At close: -
$3.84
00.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Revance Therapeutics (RVNC) Forecast
NewsEarningsRevance Therapeutics (RVNC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestRevance Therapeutics (NASDAQ:RVNC) Stock Quotes, Forecast and News Summary
Revance Therapeutics Stock (NASDAQ: RVNC) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Revance Therapeutics (RVNC) stock?
You can purchase shares of Revance Therapeutics (NASDAQ:RVNC) through any online brokerage.
Who are Revance Therapeutics (RVNC) competitors?
Other companies in Revance Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA) and GH Research (NASDAQ:GHRS).
What is the forecast, or price target, for Revance Therapeutics (RVNC) stock?
Revance Therapeutics has a consensus price target of $12.76.
What is the current price for Revance Therapeutics (RVNC)?
The stock price for Revance Therapeutics (NASDAQ: RVNC) is $3.84 last updated November 21, 2024 at 4:00 PM EST.
Does Revance Therapeutics (RVNC) pay a dividend?
There are no upcoming dividends for Revance Therapeutics.
When is Revance Therapeutics (NASDAQ:RVNC) reporting earnings?
Revance Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Revance Therapeutics (RVNC) going to split?
There is no upcoming split for Revance Therapeutics.
What sector and industry does Revance Therapeutics (RVNC) operate in?
Revance Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.